Nutra Pharma Corp (NPHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,047 | -1,286 | -1,393 | 8,177 | -13,096 |
| Depreciation Amortization | 384 | 222 | 235 | 638 | 377 |
| Accounts receivable | -21 | -7 | -1 | 24 | -9 |
| Accounts payable and accrued liabilities | 51 | 61 | 36 | 55 | 73 |
| Other Working Capital | 211 | 393 | 342 | 1,164 | 80 |
| Other Operating Activity | 258 | 193 | 232 | -10,820 | 10,830 |
| Operating Cash Flow | $-1,164 | $-424 | $-550 | $-762 | $-1,745 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -26 | N/A | 84 | -58 | -39 |
| Other Investing Activity | -25 | 41 | 34 | 85 | -255 |
| Investing Cash Flow | $-51 | $41 | $117 | $27 | $-294 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,604 | 759 | 727 | 863 | 2,394 |
| Debt Repayment | -526 | -553 | -476 | -684 | -265 |
| Other Financing Activity | 113 | 212 | 182 | 465 | 0 |
| Financing Cash Flow | $1,191 | $419 | $433 | $644 | $2,129 |
| Beginning Cash Position | 36 | N/A | 0 | 91 | N/A |
| End Cash Position | 12 | 36 | 0 | N/A | 91 |
| Net Cash Flow | $-24 | $36 | $0 | $-91 | $91 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,164 | -424 | -550 | -762 | -1,745 |
| Capital Expenditure | -26 | N/A | N/A | -58 | -39 |
| Free Cash Flow | -1,190 | -424 | -550 | -820 | -1,784 |